title: Twice-Weekly Hemodialysis in China: Can It Be A Better Option for Initiation or Maintenance Dialysis Therapy?
abstract: Cumulative evidence indicates it may be worthwhile revisiting the twice-weekly hemodialysis (HD) regimen as a valid option for individualized or incremental treatments for selected patients with end-stage renal disease. In this article, we will review the current evidences on the potential pros and cons of twice-weekly HD compared to thrice-weekly HD including China's experience in the practice of twice-weekly HD. A prudent patient selection and close dialysis adequacy monitoring might be necessary for this medical treatment choice. More randomized prospective controlled studies for the critical evaluation of twice-weekly dialysis are encouraged.
authors.affiliation: DaVita Hospital Management Consulting (Shanghai) Co.Ltd., Shanghai, China.
authors.forename: Yucheng
authors.initials: Y
authors.lastname: Yan
authors.affiliation: DaVita Healthcare Partners Inc, Singapore.
authors.forename: Sylvia
authors.initials: S
authors.lastname: Ramirez
authors.affiliation: Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA.
authors.forename: Shuchi
authors.initials: S
authors.lastname: Anand
authors.affiliation: Department of Nephrology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
authors.forename: Jiaqi
authors.initials: J
authors.lastname: Qian
authors.affiliation: Peking University People's Hospital, Beijing, China.
authors.forename: Li
authors.initials: L
authors.lastname: Zuo
mesh_terms: D002681:China / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000628:therapy*; D018579:Patient Selection; D006435:Renal Dialysis / Q000379:methods*; D016896:Treatment Outcome